References
- Araki Y, Mimura T (2017) The histone modification code in the pathogenesis of autoimmune diseases. Mediators Inflamm 2017:2608605.
https://doi.org/10.1155/2017/2608605 - Aringer M, Costenbader K, Daikh D et al. (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151–1159.
https://doi.org/10.1136/annrheumdis-2018-214819 - Bruggeman Y, Sodré FMC, Buitinga M et al. (2021) Targeting citrullination in autoimmunity: Insights learned from preclinical mouse models. Expert Opin Ther Targets 25:269–281.
https://doi.org/10.1080/14728222.2021.1918104 - Ceccarelli F, Govoni M, Piga M et al. (2022) Arthritis in systemic lupus erythematosus: From 2022 International GISEA/OEG Symposium. J Clin Med 11:6016.
https://doi.org/10.3390/jcm11206016 - Chapman EA, Lyon M, Simpson D et al. (2019) Caught in a trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus. Front Immunol 10:423.
https://doi.org/10.3389/fimmu.2019.00423 - Ciesielski O, Biesiekierska M, Panthu B et al. (2022) Citrullination in the pathology of inflammatory and autoimmune disorders: Recent advances and future perspectives. Cell Mol Life Sci 79:94.
https://doi.org/10.1007/s00018-022-04126-3 - Cortés-Hernández J, Ordi-Ros J, Labrador M et al. (2004) Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 116:165–173.
https://doi.org/10.1016/j.amjmed.2003.08.034 - Dieker J, Berden JH, Bakker M et al. (2016) Autoantibodies against modified histone peptides in SLE patients are associated with disease activity and lupus nephritis. PLoS One 11:e0165373.
https://doi.org/10.1371/journal.pone.0165373 - Eloranta ML, Alm GV, Rönnblom L (2013) Disease mechanisms in rheumatology – Tools and pathways: Plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases. Arthritis Rheum 65:853–863.
https://doi.org/10.1002/art.37821 - Farivar S, Shaabanpour Aghamaleki F (2018) Effects of major epigenetic factors on systemic lupus erythematosus. Iran Biomed J 22:294–302.
https://doi.org/10.29252/ibj.22.5.294 - Fresneda Alarcon M, McLaren Z, Wright HL (2021) Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: Same foe different M.O. Front Immunol 12:649693.
https://doi.org/10.3389/fimmu.2021.649693 - Garantziotis P, Nikolakis D, Doumas S et al. (2022) Molecular taxonomy of systemic lupus erythematosus through data-driven patient stratification: Molecular endotypes and cluster-tailored drugs. Front Immunol 13:860726.
https://doi.org/10.3389/fimmu.2022.860726 - Gautam P, Sharma A, Bhatnagar A (2021) Global histone modification analysis reveals hypoacetylated H3 and H4 histones in B cells from systemic lupus erythematosus patients. Immunol Lett 240:41–45.
https://doi.org/10.1016/j.imlet.2021.09.007 - Hakkim A, Fürnrohr BG, Amann K et al. (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 107:9813–9818.
https://doi.org/10.1073/pnas.0909927107 - Hamam HJ, Palaniyar N (2019) Post-translational modifications in NETosis and NETs-mediated diseases. Biomolecules 9:369.
https://doi.org/10.3390/biom9080369 - Hawro T, Bogucki A, Krupińska-Kun M et al. (2015) Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS One 10:e0119911.
https://doi.org/10.1371/journal.pone.0119911 - Homa-Mlak I, Mazurek M, Majdan A et al. (2022) Serum calprotectin – A NET product – As a biomarker of disease activity in patients with systemic lupus erythematosus: A single-center case-control study from Poland. Med Sci Monit 28:e936534.
https://doi.org/10.12659/MSM.936534 - Hu N, Qiu X, Luo Y et al. (2008) Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 35:804–810.
- Irure-Ventura J, López-Hoyos M (2022) Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies. J Transl Autoimmun 5:100143.
https://doi.org/10.1016/j.jtauto.2022.100143 - Jeremic I, Djuric O, Nikolic M et al. (2019) Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus. Rheumatol Int 39:1849–1857.
https://doi.org/10.1007/s00296-019-04426-1 - Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172:ITC81–ITC96.
https://doi.org/10.7326/AITC202006020 - Koike H, Furukawa S, Mouri N et al. (2022) Early ultrastructural lesions of anti-neutrophil cytoplasmic antibody-versus complement-associated vasculitis. Neuropathology 42:420–429.
https://doi.org/10.1111/neup.12821 - Lambers WM, Westra J, Bootsma H et al. (2021) From incomplete to complete systemic lupus erythematosus; a review of the predictive serological immune markers. Semin Arthritis Rheum 51:43–48.
https://doi.org/10.1016/j.semarthrit.2020.11.006 - Leffler J, Martin M, Gullstrand B et al. (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188:3522–3531.
https://doi.org/10.4049/jimmunol.1102404 - Liu Y, Lightfoot YL, Seto N et al. (2018) Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 3:e124729.
https://doi.org/10.1172/jci.insight.124729 - Malik S, Bruner GR, Williams-Weese C et al. (2007) Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus 16:863–866.
https://doi.org/10.1177/0961203307083365 - Mansouri P, Mansouri P, Behmard E et al. (2024) Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment. Int J Biol Macromol 278:134576.
https://doi.org/10.1016/j.ijbiomac.2024.134576 - Mazzone R, Zwergel C, Artico M et al. (2019) The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics 11:34.
https://doi.org/10.1186/s13148-019-0632-2 - Nurbaeva KS, Reshetnyak TM, Cherkasova M et al. (2023) Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results). Modern Rheumatol J 17:19–27.
https://doi.org/10.14412/1996-7012-2023-4-19-27 - Ohl K, Tenbrock K (2015) Regulatory T cells in systemic lupus erythematosus. Eur J Immunol 45:344–355.
https://doi.org/10.1002/eji.201344280 - Pieterse E, Hofstra J, Berden J et al. (2015) Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus. Clin Exp Immunol 179:68–74.
https://doi.org/10.1111/cei.12359 - Pisetsky DS (2020) Evolving story of autoantibodies in systemic lupus erythematosus. J Autoimmun 110:102356.
https://doi.org/10.1016/j.jaut.2019.102356 - Price JV, Tangsombatvisit S, Xu G et al. (2012) On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein–protein interactions. Nat Med 18:1434–1440.
https://doi.org/10.1038/nm.2913 - Qaddoori Y, Abrams ST, Mould P et al. (2018) Extracellular histones inhibit complement activation through interacting with complement component 4. J Immunol 200:4125–4133.
https://doi.org/10.4049/jimmunol.1700779 - Relle M, Foehr B, Schwarting A (2015) Epigenetic aspects of systemic lupus erythematosus. Rheumatol Ther 2:33–46.
https://doi.org/10.1007/s40744-015-0014-y - Rivas-Larrauri F, Yamazaki-Nakashimada MA (2016) Systemic lupus erythematosus: Is it one disease? Reumatol Clin 12:274–281.
https://doi.org/10.1016/j.reuma.2016.01.005 - Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE et al. (2021) Seizures in systemic lupus erythematosus: A scoping review. Seizure 86:161–167.
https://doi.org/10.1016/j.seizure.2021.02.021 - Ronchetti L, Terrenato I, Ferretti M et al. (2022) Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res 41:151.
https://doi.org/10.1186/s13046-022-02359-5 - Saisorn W, Saithong S, Phuengmaung P et al. (2021) Acute kidney injury induced lupus exacerbation through the enhanced neutrophil extracellular traps (and apoptosis) in Fcgr2b deficient lupus mice with renal ischemia reperfusion injury. Front Immunol 12:669162.
https://doi.org/10.3389/fimmu.2021.669162 - Salemme R, Peralta LN, Meka SH et al. (2019) The role of NETosis in systemic lupus erythematosus. J Cell Immunol 1:33–42.
https://doi.org/10.33696/immunology.1.008 - Samotij D (2018) Treatment of systemic lupus erythematosus – Future challenges and prospects. Forum Dermatol 4:70–77.
- Sandling JK, Pucholt P, Hultin Rosenberg L et al. (2021) Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing. Ann Rheum Dis 80:109–117.
https://doi.org/10.1136/annrheumdis-2020-218636 - Senda A, Sasai R, Kato K et al. (2022) Involvement of neutrophil extracellular traps in the pathogenesis of glomerulonephritis in a case of systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome. CEN Case Rep 11:339–346.
https://doi.org/10.1007/s13730-021-00682-y - Shang X, Ren L, Sun G et al. (2021) Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immun Inflamm Dis 9:407–418.
https://doi.org/10.1002/iid3.401 - Sharma P, Azebi S, England P et al. (2012) Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS Genet 8:e1002934.
https://doi.org/10.1371/journal.pgen.1002934 - Sim TM, Mak A, Ta SH (2022) Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions. Front Immunol 13:957303.
https://doi.org/10.3389/fimmu.2022.957303 - van der Vlag J, Berden JH (2011) Lupus nephritis: Role of antinucleosome autoantibodies. Semin Nephrol 31:376–389.
https://doi.org/10.1016/j.semnephrol.2011.06.009 - Wannberg F, Hjalmar V, Ng H et al. (2024) Plasma H3Cit-DNA discriminates between cancer and inflammation in a cohort of patients with unspecific cancer symptoms. Inflammation.
https://doi.org/10.1007/s10753-024-02085-4 - Weinstein A, Alexander RV, Zack DJ (2021) A review of complement activation in SLE. Curr Rheumatol Rep 23:16.
https://doi.org/10.1007/s11926-021-00984-1 - Zhou Y, Qiu X, Luo Y et al. (2011) Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus 20:1365–1371.
https://doi.org/10.1177/0961203311413412